Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

797
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
797
Drug Elimination: Non-Renal Routes01:23

Drug Elimination: Non-Renal Routes

2.9K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.9K
The Blood-brain Barrier00:49

The Blood-brain Barrier

51.9K
Overview
51.9K
Drug Excretion: Miscellaneous Routes01:10

Drug Excretion: Miscellaneous Routes

277
Drug excretion involves various organs, including the liver, intestines, skin, and eyes. In the case of drugs or toxins, they can be actively secreted into bile by transporters in the hepatocyte's canalicular membrane. These substances enter the GI tract during digestion and may be reabsorbed into the body from the intestine. This process, known as enterohepatic recycling, can significantly prolong the presence and effects of a substance in the body. To interrupt this cycle, specific...
277
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

4.7K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
4.7K
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

142
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
142

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decoupling CAR-T Expansion, Conversion, and Decay Timing: Physiologically Aligned Semi-Mechanistic Modeling With Smooth Gating and a Cauchy Likelihood Residual Model.

Journal of clinical pharmacology·2026
Same author

Comparing heavy-tailed residual error models for outlier handling in population PK modeling.

Journal of pharmacokinetics and pharmacodynamics·2026
Same author

Partial Differential Equation (PDE)-Based Spatial Pharmacometrics in NONMEM: Method of Lines (MOL) Implementation with AI-Assisted Model Development.

Journal of clinical pharmacology·2026
Same author

Delay differential equation (DDE) modeling of CAR-T cellular kinetics: Application to BCMA-targeted (Ide-cel, Orva-cel) and CD19-targeted (Lisocel) therapies.

Journal of pharmaceutical sciences·2026
Same author

A Perspective on the Use of Poisson Versus Logistic Regression in Exposure-Response Analysis: Insights and Considerations.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Integrative population pharmacokinetic modeling of two BCMA-targeted and one CD19-targeted CAR-T therapies using full Bayesian inference with a student's t-based M3 censoring approach for robust handling of outliers and BLQ data.

Journal of pharmaceutical sciences·2025

Related Experiment Video

Updated: Dec 29, 2025

A Simple and Reproducible Method to Prepare Membrane Samples from Freshly Isolated Rat Brain Microvessels
07:13

A Simple and Reproducible Method to Prepare Membrane Samples from Freshly Isolated Rat Brain Microvessels

Published on: May 7, 2018

10.6K

How does the brain remove its waste metabolites from within?

Yiming Cheng1, James Haorah1

  • 1Laboratory of Neurovascular Inflammation and Neurodegeneration, Department of Biomedical Engineering, Center for Injury Bio Mechanics, Materials and Medicine, New Jersey Institute of Technology Newark, NJ 07102, United States.

International Journal of Physiology, Pathophysiology and Pharmacology
|January 30, 2020
PubMed
Summary

The brain uses specialized pathways to clear waste metabolites, which are harmful byproducts of normal function. Since the brain lacks a lymphatic system, it relies on cerebrospinal fluid (CSF) to clear small solutes. However, larger waste products like Aβ protein require an alternative route. This review discusses perivascular clearance (PVC), a newly identified pathway that allows waste to move from the interstitial space into perivascular regions, either directly or via CSF. The authors suggest that improving this pathway could help reduce the buildup of harmful waste and potentially treat neurological diseases.

Keywords:
Central nervous system (CNS) clearanceblood-brain barrier (BBB)cerebrospinal fluid (CSF)interstitial fluid (ISF)perivascular spacebrain waste clearanceperivascular clearance pathwaycerebrospinal fluid functionneurological disease mechanisms

Frequently Asked Questions

More Related Videos

Metabolomic Analysis of Rat Brain by High Resolution Nuclear Magnetic Resonance Spectroscopy of Tissue Extracts
09:01

Metabolomic Analysis of Rat Brain by High Resolution Nuclear Magnetic Resonance Spectroscopy of Tissue Extracts

Published on: September 21, 2014

15.2K
Purification of Mouse Brain Vessels
07:32

Purification of Mouse Brain Vessels

Published on: November 10, 2015

24.6K

Related Experiment Videos

Last Updated: Dec 29, 2025

A Simple and Reproducible Method to Prepare Membrane Samples from Freshly Isolated Rat Brain Microvessels
07:13

A Simple and Reproducible Method to Prepare Membrane Samples from Freshly Isolated Rat Brain Microvessels

Published on: May 7, 2018

10.6K
Metabolomic Analysis of Rat Brain by High Resolution Nuclear Magnetic Resonance Spectroscopy of Tissue Extracts
09:01

Metabolomic Analysis of Rat Brain by High Resolution Nuclear Magnetic Resonance Spectroscopy of Tissue Extracts

Published on: September 21, 2014

15.2K
Purification of Mouse Brain Vessels
07:32

Purification of Mouse Brain Vessels

Published on: November 10, 2015

24.6K

Area of Science:

  • Neurophysiology
  • Neurological waste clearance mechanisms
  • Blood-brain barrier function

Background:

The brain requires constant energy to regulate essential functions like circulation and respiration. This energy is supplied through active transport of nutrients across the blood-brain barrier (BBB). While this process is normal, the movement of harmful substances like xenobiotics or inflammatory agents across these interfaces can damage brain cells. This damage leads to the accumulation of waste metabolites. The brain lacks a lymphatic system, so cerebrospinal fluid (CSF) is used to clear small solutes. However, larger waste products like Aβ protein are not efficiently removed through this pathway. This gap in understanding motivates a closer look at how waste is cleared from the brain. Prior research has identified the BBB, blood-spinal cord barrier, and choroid plexus as key interfaces. Yet, the mechanisms for removing large waste metabolites remain unclear. This uncertainty drives the need to explore alternative pathways like perivascular clearance.

Purpose Of The Study:

This review aims to clarify how waste metabolites are cleared from the brain. The focus is on the interfaces that regulate transport into and out of the central nervous system (CNS). The BBB, blood-spinal cord barrier, and choroid plexus are central to this discussion. The review also considers the harmful effects of xenobiotics and inflammatory agents crossing these barriers. The accumulation of waste metabolites is linked to neurological complications. Since the CNS lacks a lymphatic system, alternative pathways like perivascular clearance (PVC) are of interest. The goal is to identify mechanisms that allow waste to move from the interstitial space into PVC or via IS-CSF-PVC. The study also aims to explore how these pathways exchange waste metabolites into the circulation for removal.

Main Methods:

The authors conducted a literature review focusing on the CNS interfaces that regulate waste clearance. They examined the BBB, blood-spinal cord barrier, and choroid plexus as primary sites of transport. The review also included recent findings on perivascular clearance (PVC) and its role in removing waste metabolites. The authors analyzed the movement of waste from the interstitial space (IS) into PVC or via IS-CSF-PVC pathways. They evaluated how these pathways facilitate the exchange of waste metabolites into the circulation. The study did not involve new experiments but synthesized existing evidence. The authors compared the efficiency of CSF-based clearance for small solutes versus larger waste products like Aβ protein. The review approach included a detailed analysis of how xenobiotics and inflammatory agents contribute to waste accumulation.

Main Results:

The review highlights that the BBB and related interfaces are essential for transporting nutrients into the brain. However, these same interfaces allow harmful substances to enter, leading to waste metabolite production. The CNS lacks a lymphatic system, so CSF is used to clear small solutes but not large waste like Aβ protein. The review identifies perivascular clearance (PVC) as a key pathway for removing larger waste metabolites. Waste can move directly from the interstitial space (IS) into PVC or via IS-CSF-PVC. The exchange of waste from PVC into the circulation is also discussed. The study found that PVC is more effective for clearing large waste metabolites than CSF alone. The review suggests that improving PVC function could enhance waste clearance and reduce neurological complications.

Conclusions:

The authors propose that perivascular clearance (PVC) is a critical mechanism for removing large waste metabolites from the brain. Since the CNS lacks a lymphatic system, alternative pathways like PVC are necessary for maintaining brain homeostasis. The review suggests that the movement of waste from the interstitial space into PVC or via IS-CSF-PVC is a viable clearance route. The exchange of waste from PVC into the circulation is also important for complete removal. The authors highlight that xenobiotics and inflammatory agents contribute to waste accumulation and neurological complications. They propose that improving PVC function could be a therapeutic strategy for neurological diseases. The review concludes that understanding these clearance mechanisms is essential for developing new treatments. The findings suggest that enhancing waste clearance could ameliorate neurological conditions.

PVC is a pathway that allows waste metabolites to move from the interstitial space into perivascular regions, either directly or via cerebrospinal fluid.

The brain uses perivascular clearance (PVC) to remove large waste metabolites, as the lymphatic system is absent and cerebrospinal fluid alone is insufficient.

The BBB regulates nutrient transport but also allows harmful substances to enter, leading to waste metabolite accumulation that requires clearance mechanisms like PVC.

CSF clears small solutes but not large waste metabolites like Aβ protein, which rely on perivascular clearance pathways for removal.

The IS is the site where waste metabolites accumulate before being transported into perivascular clearance pathways for removal.

The authors propose that enhancing PVC function could reduce waste accumulation and ameliorate neurological complications like those seen in Alzheimer’s disease.